Pfizer’s Litfulo approved in Europe to treat severe alopecia areata

By NS Healthcare Staff Writer

20 Sep 23

Litfulo works by irreversibly and selectively inhibiting JAK3 and the TEC family of kinases by blocking γ-common cytokine…

PharmaceuticalsRegulation

Merck unveils two strategic collaborations to enhance AI-driven drug discovery

By NS Healthcare Staff Writer

20 Sep 23

The primary aim of these collaborations is to advance Merck's research endeavours and generate a range of innovative…

PharmaceuticalsPartnerships and Licensing Agreements

PeptiDream, Genentech partner for peptide-RI drug conjugates discovery

By NS Healthcare Staff Writer

20 Sep 23

Under the agreement, PeptiDream will leverage its PDPS technology to discover, optimise, and develop macrocyclic peptide candidates for…

PharmaceuticalsPartnerships and Licensing Agreements

BioNTech, CEPI partner to boost mRNA-based mpox vaccine development

By NS Healthcare Staff Writer

19 Sep 23

CEPI will contribute up to $90m funding for the partnership, which will support the development of mRNA-based vaccine…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

ViiV Healthcare receives EC approval for Apretude to prevent HIV

By NS Healthcare Staff Writer

19 Sep 23

Cabotegravir is approved for use in combination with safer sex practices as a pre-exposure prophylaxis (PrEP) method and…

PharmaceuticalsRegulation

Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture antibody cancer drug substance

By NS Healthcare Staff Writer

19 Sep 23

Under the terms of the new agreement, Samsung Biologics will provide drug substance manufacturing for an antibody cancer…

PharmaceuticalsPartnerships and Licensing Agreements

Pharmazz partners with Sun Pharma to commercialise Tyvalzi in India

By NS Healthcare Staff Writer

15 Sep 23

The agreement provides Sun Pharma with rights to commercialise Tyvalzi (Sovateltide) for the treatment of acute cerebral ischemic…

PharmaceuticalsPartnerships and Licensing Agreements

Astellas to invest €330m to build new drug product facility in Ireland

By NS Healthcare Staff Writer

15 Sep 23

The investment is expected to expand Astellas’ capacity and capabilities for aseptic drug products in Ireland, strengthen stable…

PharmaceuticalsEngineering and Construction

Generate:Biomedicines raises $273m to advance preclinical pipeline

By NS Healthcare Staff Writer

15 Sep 23

US-based Generate:Biomedicines will use the funds to advance its portfolio of 17 existing programmes across oncology, immunology, and…

PharmaceuticalsDrug discovery

Nona Biosciences Expands Antibody Discovery Collaboration with BeiGene

By NS Healthcare Staff Writer

15 Sep 23

Through the collaboration, BeiGene will be granted access to Nona Biosciences' proprietary fully human transgenic mice platform Harbour…

PharmaceuticalsDrug discovery